Preclinical study of amphiphilic amines (RC16) for cancer treatment
Sponsored by: Open Therapeutics™

  1. Home
  2. Grants
  3. Preclinical study of amphiphilic amines (RC16) for cancer treatment

Abstract:

Sponsored by Open Therapeutics. Matching funds are being sought. Details coming soon…

This grant will award up to $3,000.00 USD or 30000.00 SCI towards the winning proposal(s).

Proposals that utilize the following Technologies will be considered:

Therapod project tittle A novel class of antitumor amphiphilic amines (RCn)

Grant issuance date: 2022-02-22 09:14 UTC

Proposal submissions: Ended on 2022-05-15 15:25 UTC

Voting Period: Ended on 2022-06-15 00:00 UTC